Ad
related to: can sertraline make anxiety worse in the beginning of years
Search results
Results From The WOW.Com Content Network
Regardless of why you’re taking sertraline, there’s a good chance you’ll encounter side effects in the first weeks. Like other SSRIs, sertraline can cause a range of possible side effects ...
Sertraline, sold under the brand name Zoloft among others, is an antidepressant medication of the selective serotonin reuptake inhibitor (SSRI) class [10] used to treat major depressive disorder, generalized anxiety disorder, social anxiety disorder, obsessive–compulsive disorder (OCD), panic disorder, and premenstrual dysphoric disorder. [11]
SSRIs are modern antidepressants often used as a first-line treatment for major depressive disorder. Common SSRIs include Prozac (fluoxetine), Zoloft (sertraline) and Lexapro (escitalopram ...
Occasionally symptoms can last up to one year. [3] They typically resolve within a day of restoring the medication. [20] Paroxetine and venlafaxine seem to be particularly difficult to discontinue, and prolonged withdrawal syndrome (post-acute-withdrawal syndrome, or PAWS) lasting over 18 months has been reported with paroxetine. [21] [22] [23]
The NHS says mirtazapine can make patients feel sleepy, which means it can help with difficulties getting to sleep. The most recent data shows 5.2 million patients were prescribed SSRIs in 2021 ...
Paroxetine was the first drug to be approved for social anxiety disorder and it is considered effective for this disorder; sertraline and fluvoxamine were later approved for it as well. Escitalopram and citalopram are used off-label with acceptable efficacy, while fluoxetine is not considered to be effective for this disorder. [ 22 ]
Sertraline (Zoloft) As an SSRI antidepressant, escitalopram is commonly prescribed to treat depression. The FDA also approves it for the treatment of generalized anxiety disorder (GAD).
In some people, this state change can increase suicidal tendencies, especially in those under age 25 and during the initial weeks of treatment. [2] SSRI-induced activation syndrome is well-accepted by clinicians. [3] It is unclear whether jitteriness/anxiety syndrome predicts either good or poor prognosis (level D). [4]